{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-022093","form_type":"8-K","ticker":"PVCT","cik":"0000315545","company_name":"PROVECTUS BIOPHARMACEUTICALS, INC.","filed_at":"2021-09-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:20.277930+00:00","generated_at":"2026-06-29T05:38:20.481578+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Provectus reports fully diluted shares of 528.7M as of Sep 7, 2021, down from 563.9M in 2017","bullets":["Fully diluted shares outstanding as of Sep 7, 2021: 528,667,356 vs 563,911,848 in 2017.","Common shares outstanding: 416,575,669; warrants: 512,500; options: 4,800,000; Series D/D-1 conversion shares: 106,779,187.","All Private Warrants expired by Oct 31, 2020; Listed Warrants expired Jun 23, 2020.","Convertible notes ($30.56M) converted into Series D/D-1 Preferred on Jun 20, 2021, convertible into ~106.8M common shares.","Remaining Series B Preferred converted Aug 25, 2021; 13.35M Ratchet Warrants exercised, 68.7M expired by Aug 30, 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-022093","json":"https://secwatch.observer/filing/0001493152-21-022093.json","markdown":"https://secwatch.observer/filing/0001493152-21-022093.md","text":"https://secwatch.observer/filing/0001493152-21-022093.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/315545/000149315221022093/0001493152-21-022093-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/315545/000149315221022093/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T05:38:20.481578+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}